Takeda Pharmaceuticals has announced plans to reduce its workforce by 250 positions at its Cambridge location, effective July 2026.
This decision reflects ongoing adjustments within the biopharmaceutical sector, which may affect operational throughput and resource allocation.
As the largest biopharma employer in Massachusetts, these layoffs could have significant implications for local employment and industry dynamics.